Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series B venture round brings in $12.5mm so far for Nanostim

Executive Summary

Nanostim Inc., developer of a miniaturized leadless pacemaker, has raised $12.5mm through its Series B venture round from five undisclosed investors. According to the company’s Form D filing, it could bring in an additional $611k before closing the financing. Nanostim also closed a $5mm debt transaction this month.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register